Clinical TrialsSearch results
Number of results: 596
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Clinical study of combinational therapy of AD-4833 with metformin -Phase III double-blind comparative study-
- Type2 Diabetes
- Takeda Pharmaceutical Company Limited
- 2008-04-04
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to an Alpha-Glucosidase Inhibitor
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2008-10-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Thiazolidine
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2008-10-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Sulfonylurea
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2009-04-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Metformin
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2009-04-01
Other
- ATOMen study
- endometrial cancer
- Takanashi Nobutaka
- 2024-03-06
Completed
- Phase III Study of PEM + CDDP and VNR + CDDP for Completely Resected Non-squamous Non-Small Cell Lung Cancer
- Completely Resected Non-squamous Non-Small Cell Lung Cancer
- Takahashi Toshiaki
- 2018-12-20
Completed
- Phase II study of low-dose afatinib for elderly NSCLC patients
- Non-small cell lung cancer
- Takahashi Toshiaki
- 2019-02-27
Completed
- A phase I study of chemoradiotherapy using CBDCA + nab-PTX for elderly stage III NSCLC
- Clinical stage III non-small-cell lung cancer
- Takahashi Toshiaki
- 2019-03-11
Completed
- A phase 2 study of afatinib for NSCLC with uncommon EGFR mutation detected by NGS
- Non-small cell lung cancer with uncommon EGFR mutaiton
- Takahashi Toshiaki
- 2019-05-20